Background: Dotinurad is a novel selective urate transporter 1 (URAT1) inhibitor recently introduced in Japan. This study aims to evaluate the efficacy and safety of dotinurad in hyperuricemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback